AVDL

Avadel Pharmaceuticals
AVDL

Overview Fund Activity

175 hedge funds and large institutions have $976M invested in Avadel Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 58 increasing their positions, 43 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
175
Holders Change
+21
Holders Change %
+13.64%
% of All Funds
2.53%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
46
Increased
58
Reduced
43
Closed
25
Calls
$35.8M
Puts
$48.9M
Net Calls
-$13M
Net Calls Change
-$33.5M

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$24.4M
2
Millennium Management
2
Millennium Management
New York
$12.8M
3
PCM
3
Penn Capital Management
Pennsylvania
$8M
4
Northern Trust
4
Northern Trust
Illinois
$7.76M
5
B
5
Braidwell
Connecticut
$44.4M

Top Sellers

1
PCH
1
Polar Capital Holdings
United Kingdom
$63.4M
2
VC
2
Vivo Capital
California
$35.2M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$0
4
MB
4
MPM BioImpact
Massachusetts
$0
5
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
KCM
26
Knoll Capital Management
Florida
$7.87M – – –
Northern Trust
27
Northern Trust
Illinois
$7.76M +$7.76M +591,634 New
KCM
28
Kennedy Capital Management
Missouri
$7.71M -$865K -65,939 -10%
Lord, Abbett & Co
29
Lord, Abbett & Co
New Jersey
$6.41M +$6.41M +489,073 New
Bank of America
30
Bank of America
North Carolina
$6.33M -$2.75M -209,887 -30%
Deutsche Bank
31
Deutsche Bank
Germany
$6.25M -$1.67M -127,666 -21%
New York State Common Retirement Fund
32
New York State Common Retirement Fund
New York
$5.52M +$5.03M +383,355 +1,025%
Barclays
33
Barclays
United Kingdom
$5.15M +$1.62M +123,430 +46%
CCM
34
Cutter Capital Management
New York
$5.05M -$4.56M -347,829 -47%
Ameriprise
35
Ameriprise
Minnesota
$4.54M +$597K +45,530 +15%
DMKJ
36
David M. Knott Jr
$4.35M -$13.1K -1,000 -0.3%
PHP
37
Parkman Healthcare Partners
Connecticut
$3.34M -$1.62M -123,462 -33%
Nuveen Asset Management
38
Nuveen Asset Management
Illinois
$3.29M – – –
Bank of New York Mellon
39
Bank of New York Mellon
New York
$2.96M -$1.3M -99,322 -31%
Qube Research & Technologies (QRT)
40
Qube Research & Technologies (QRT)
United Kingdom
$2.96M +$2.96M +225,970 New
Charles Schwab
41
Charles Schwab
California
$2.89M -$4.42K -337 -0.2%
Marshall Wace
42
Marshall Wace
United Kingdom
$2.57M +$2.57M +195,892 New
IAM
43
Iridian Asset Management
Connecticut
$2.2M +$656K +50,000 +42%
Balyasny Asset Management
44
Balyasny Asset Management
Illinois
$2.18M -$1.55M -118,036 -42%
Swiss National Bank
45
Swiss National Bank
Switzerland
$1.97M +$1.97M +150,200 New
DWA
46
Dorsey Wright & Associates
California
$1.86M +$213K +16,215 +13%
SC
47
Schulhoff & Co
Ohio
$1.8M – – –
MML Investors Services
48
MML Investors Services
Massachusetts
$1.79M +$216K +16,500 +14%
Squarepoint
49
Squarepoint
New York
$1.69M +$1.69M +128,615 New
D.E. Shaw & Co
50
D.E. Shaw & Co
New York
$1.65M +$1.2M +91,290 +262%
1
2
3 4 5